113 related articles for article (PubMed ID: 38336184)
21. [Exploration of the therapeutic mechanism of
Xu M; Zhang P; Zhang G
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jun; 42(6):805-814. PubMed ID: 35790430
[TBL] [Abstract][Full Text] [Related]
22. Study on the chemical constituents and mechanism of Kai-Xin-San based on UPLC-Q-Exactive MS and network pharmacology.
Shang B; Jia S; Zhang T; Gao F; Lu M; Chen K; Jiao J; Dai Z; Zeng Q; Xu B; Lei H
J Ethnopharmacol; 2024 Mar; 322():117652. PubMed ID: 38151178
[TBL] [Abstract][Full Text] [Related]
23. Integrated plasma pharmacochemistry and network pharmacology to explore the mechanism of Gerberae Piloselloidis Herba in treatment of allergic asthma.
Zhou K; Lu D; You J; Liu T; Sun J; Lu Y; Pan J; Li Y; Liu C
J Ethnopharmacol; 2022 Nov; 298():115624. PubMed ID: 35970314
[TBL] [Abstract][Full Text] [Related]
24. Prediction of the mechanism of Dachengqi Decoction treating colorectal cancer based on the analysis method of " into serum components -action target-key pathway".
Yin FT; Zhou XH; Kang SY; Li XH; Li J; Ullah I; Zhang AH; Sun H; Wang XJ
J Ethnopharmacol; 2022 Jul; 293():115286. PubMed ID: 35413412
[TBL] [Abstract][Full Text] [Related]
25. A novel and comprehensive strategy for quality control in complex Chinese medicine formula using UHPLC-Q-Orbitrap HRMS and UHPLC-MS/MS combined with network pharmacology analysis: Take Tangshen formula as an example.
Wang X; Zhou W; Wang Q; Zhang Y; Ling Y; Zhao T; Zhang H; Li P
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1183():122889. PubMed ID: 34626904
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
[TBL] [Abstract][Full Text] [Related]
27. Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments.
Peng H; Huang Z; Li P; Sun Z; Hou X; Li Z; Sang R; Guo Z; Wu S; Cao Y
J Ethnopharmacol; 2024 Mar; 321():117518. PubMed ID: 38042385
[TBL] [Abstract][Full Text] [Related]
28. Integrated phytochemistry and network pharmacology analysis to reveal effective substances and mechanisms of Bushen Quhan Zhiwang decoction in the treatment of rheumatoid arthritis.
Zhang LB; Yan Y; Ma R; Li DX; Yin WF; Tao QW; Xu Y
J Ethnopharmacol; 2024 May; 325():117897. PubMed ID: 38336180
[TBL] [Abstract][Full Text] [Related]
29. Discovery of Biomarkers and Potential Mechanisms of Agarwood Incense Smoke Intervention by Untargeted Metabolomics and Network Pharmacology.
Dong M; Du H; Li X; Zhang L; Wang X; Wang Z; Jiang H
Drug Des Devel Ther; 2022; 16():265-278. PubMed ID: 35115762
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma.
Wang N; Feng Y; Tan HY; Cheung F; Hong M; Lao L; Nagamatsu T
J Ethnopharmacol; 2015 Apr; 164():309-18. PubMed ID: 25700642
[TBL] [Abstract][Full Text] [Related]
31. Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma.
Xia J; Rong L; Sawakami T; Inagaki Y; Song P; Hasegawa K; Sakamoto Y; Tang W
Biomed Pharmacother; 2018 Mar; 99():921-930. PubMed ID: 29710492
[TBL] [Abstract][Full Text] [Related]
32. A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification.
Li S; Hao L; Hu X; Li L
Infect Agent Cancer; 2023 Jul; 18(1):41. PubMed ID: 37393234
[TBL] [Abstract][Full Text] [Related]
33. Prediction of the mechanisms of Xiaoai Jiedu Recipe in the treatment of breast cancer: A comprehensive approach study with experimental validation.
Li Y; Li R; Zeng Z; Li S; Luo S; Wu J; Zhou C; Xu D
J Ethnopharmacol; 2020 Apr; 252():112603. PubMed ID: 31981747
[TBL] [Abstract][Full Text] [Related]
34. Kuntai capsule attenuates premature ovarian insufficiency by activating the FOXO3/SIRT5 signaling pathway in mice: A comprehensive study using UHPLC-LTQ-Orbitrap and integrated pharmacology.
Gong L; Hou J; Yang H; Zhang X; Zhao J; Wang L; Yin X; Feng X; Yin C
J Ethnopharmacol; 2024 Mar; 322():117625. PubMed ID: 38145859
[TBL] [Abstract][Full Text] [Related]
35. Diterpenoid anthraquinones as chemopreventive agents altered microRNA and transcriptome expressions in cancer cells.
Su YS; Kuo MZ; Kuo YT; Huang SW; Lee CJ; Su ZY; Ni YH; Li DK; Wu TY
Biomed Pharmacother; 2021 Apr; 136():111260. PubMed ID: 33465676
[TBL] [Abstract][Full Text] [Related]
36. Integrated metabolism, network pharmacology, and pharmacokinetics to explore the exposure differences of the pharmacodynamic material basis in vivo caused by different extraction methods for Saussurea involucrata.
Yang L; Lyu H; Yiming A; Xu X; Ma C; Tu S; Chen B; Liu M; Wu C
J Ethnopharmacol; 2022 Nov; 298():115648. PubMed ID: 35987408
[TBL] [Abstract][Full Text] [Related]
37. Exploring the effect of Gupi Xiaoji Prescription on hepatitis B virus-related liver cancer through network pharmacology and in vitro experiments.
Yu S; Gao W; Zeng P; Chen C; Zhang Z; Liu Z; Liu J
Biomed Pharmacother; 2021 Jul; 139():111612. PubMed ID: 33915505
[TBL] [Abstract][Full Text] [Related]
38. A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology.
Yin X; Li J; Hao Z; Ding R; Qiao Y
Front Cell Infect Microbiol; 2022; 12():964469. PubMed ID: 36046748
[TBL] [Abstract][Full Text] [Related]
39. Identifying potential active components of walnut leaf that action diabetes mellitus through integration of UHPLC-Q-Orbitrap HRMS and network pharmacology analysis.
Liu R; Su C; Xu Y; Shang K; Sun K; Li C; Lu J
J Ethnopharmacol; 2020 May; 253():112659. PubMed ID: 32058009
[TBL] [Abstract][Full Text] [Related]
40. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
